TFF Pharmaceuticals, Inc. (TFFP)
Dec 13, 2024 - TFFP was delisted (reason: winding down operations)
0.0650
-0.0977 (-60.05%)
Inactive · Last trade price on Dec 12, 2024
Blueprint Medicines Employees
TFF Pharmaceuticals had 19 employees as of December 31, 2023. The number of employees increased by 4 or 26.67% compared to the previous year.
Employees
19
Change (1Y)
4
Growth (1Y)
26.67%
Revenue / Employee
$61,116
Profits / Employee
-$974,827
Market Cap
288.80K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 19 | 4 | 26.67% |
| Dec 31, 2022 | 15 | 11 | 275.00% |
| Dec 31, 2020 | 4 | 0 | - |
| Dec 31, 2019 | 4 | -3 | -42.86% |
| Dec 31, 2018 | 7 | 0 | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
TFFP News
- 6 months ago - TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration - PRNewsWire
- 9 months ago - TFF Pharmaceuticals Announces It Will Wind Down Operations - GlobeNewsWire
- 11 months ago - TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID - GlobeNewsWire
- 11 months ago - TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing - GlobeNewsWire